Intellia Therapeutics, Inc. (NTLA)
9.19
-0.11
(-1.18%)
USD |
NASDAQ |
Dec 10, 09:37
Intellia Therapeutics Total Liabilities (Quarterly): 176.85M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 902.34M |
| Regeneron Pharmaceuticals, Inc. | 9.212B |
| Beam Therapeutics, Inc. | 345.08M |
| Vertex Pharmaceuticals, Inc. | 7.544B |
| Pacific Biosciences of California, Inc. | 767.07M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 925.28M |
| Shareholders Equity (Quarterly) | 748.42M |
| Debt to Equity Ratio | 0.1309 |
| Current Ratio | 6.209 |
| Net Debt Paydown Yield | 0.08% |